Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Aliment Pharmacol Ther. 2014 Jul 16;40(5):498–507. doi: 10.1111/apt.12861

Table 2.

IBD Clinical Characteristics

Factor CD (N=51) UC (N=11)
Age at Diagnosis (years) 12.4±3.5 13.2±3.7
IBD Duration (years) 2.9[1.09,4.4] 6.6[1.6,7.3]
IBD surgery 9(17.6) 0(0.0)
Family history of IBD 22(43.1) 5(45.5)
Medications
        5-aminosalicylate (5-ASA) 34(66.7) 10(90.9)
        Azathioprine/Mercaptopurine 14(27.5) 3(27.3)
        Methotrexate 6(11.8) 0(0.0)
        Anti-TNF 29(56.9) 7(63.6)
        Prednisone 7(13.7) 2(18.2)
Hemoglobin (g/dL) 12.8[11.7,13.9] 12.2[11.5,14.1]
Hematocrit (%) 38.7[35.6,40.6] 37.7[35.5,42.2]
ESR (mm/hr) 4.0[1.00,9.0] 5.0[1.00,10.0]
CRP (mg/dL) 0.10[0.10,0.10] 0.10[0.10,0.10]
WBC (k/uL) 6.9[5.7,9.0] 7.5[5.7,8.5]
Platelets (k/uL) 286.0[230.0,350.0] 246.0[206.0,370.0]
Albumin (g/dL) 4.2[4.1,4.5] 4.4[3.5,4.5]
PCDAI Score 4.8 ± 8.4 ---
PUCAI Score --- 14.2 ± 15.5

Values presented as Mean ± SD, Median [P25, P75] or N (%).